PCR
PCR-based testing identifying genetic materials for onychomycosis
PCR Turnaround Time: 24-48 Hours
Accurate Pathogen Identification for Prompt and Targeted Anti-fungal Treatment
Shown to be twice as sensitive as culture when identifying dermatophytes as the causative organism
Organism identification to complement high sensitivity PAS/GMS stains without substantially increasing turn-around-time
Organism Genus and Species may be necessary for pre-authorization of new topical anti-fungal medications
click image to enlarge
PCR Technology Workflow for Onychomycosis Testing
Bako’s proprietary, patent-pending PCR technology identifies the genus and species of the fungus causing onychomycosis enabling proper use of therapeutics and appropriate coverage within the FDA indication
click image to enlarge
Bako’s Onychomycosis PCR Intelligence Report
Bako’s PCR report identifies genus and species while providing medically relevant information to help optimize care
click image to enlarge
click image to enlarge
National Health Plans’ Requirements
Antifungal pharmacy programs require positive lab report at the species level and reference PCR availability
Additional Pathology Services
Histopathologic, histochemical, and/or immunophenotypic examination of skin, soft tissue, bone, and cytology obtained though biopsy, excision amputation
Conventional growth-based microbiology testing for the presence of microorganisms in a sample
Qualification and quantification of small fiber peripheral neuropathy
Utilizes immunohistochemistry and morphometric analysis